Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor EM Bowers, G Yan, C Mukherjee, A Orry, L Wang, MA Holbert, NT Crump, ... Chemistry & biology 17 (5), 471-482, 2010 | 715 | 2010 |
Isolation and characterisation of microsatellites from hexaploid bread wheat GJ Bryan, AJ Collins, P Stephenson, A Orry, JB Smith, MD Gale theoretical and Applied Genetics 94, 557-563, 1997 | 493 | 1997 |
Analyses of circular dichroism spectra of membrane proteins BA Wallace, JG Lees, AJW Orry, A Lobley, RW Janes Protein Science 12 (4), 875-884, 2003 | 207 | 2003 |
Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening CN Cavasotto, AJW Orry, NJ Murgolo, MF Czarniecki, SA Kocsi, ... Journal of medicinal chemistry 51 (3), 581-588, 2008 | 197 | 2008 |
Efficient synthetic inhibitors of anthrax lethal factor M Forino, S Johnson, TY Wong, DV Rozanov, AY Savinov, W Li, ... Proceedings of the National Academy of Sciences 102 (27), 9499-9504, 2005 | 166 | 2005 |
Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors CN Cavasotto, AJW Orry, RA Abagyan Proteins: Structure, Function, and Bioinformatics 51 (3), 423-433, 2003 | 103 | 2003 |
Structure-based development of target-specific compound libraries AJW Orry, RA Abagyan, CN Cavasotto Drug discovery today 11 (5-6), 261-266, 2006 | 102 | 2006 |
Modeling and docking the endothelin G-protein-coupled receptor AJW Orry, BA Wallace Biophysical Journal 79 (6), 3083-3094, 2000 | 71 | 2000 |
The challenge of considering receptor flexibility in ligand docking and virtual screening CN Cavasotto, AJW Orry, RA Abagyan Current Computer-Aided Drug Design 1 (4), 423-440, 2005 | 64 | 2005 |
ICM manual RA Abagyan, A Orry, E Raush, L Budagyan, M Totrov La Jolla: MolSoft LLC, 2012 | 53* | 2012 |
Structured documents and systems, methods and computer programs for creating, producing and displaying three dimensional objects and other related information in those … R Abagyan, E Raush, M Totrov, L Budagyan, AJW Orry US Patent 7,880,738, 2011 | 50 | 2011 |
Homology modeling: methods and protocols AJW Orry, R Abagyan Humana Press, 2012 | 45 | 2012 |
Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping M Dong, X Xu, AM Ball, JA Makhoul, PCH Lam, DI Pinon, A Orry, ... The FASEB Journal 26 (12), 5092, 2012 | 43 | 2012 |
Structural evidence for a role of the multi-functional human glycoprotein afamin in Wnt transport A Naschberger, A Orry, S Lechner, MW Bowler, D Nurizzo, M Novokmet, ... Structure 25 (12), 1907-1915. e5, 2017 | 34 | 2017 |
Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore M Dong, PCH Lam, DI Pinon, K Hosohata, A Orry, PM Sexton, R Abagyan, ... Journal of Biological Chemistry 286 (27), 23888-23899, 2011 | 32 | 2011 |
Molecular basis for binding and subtype selectivity of 1, 4-benzodiazepine antagonist ligands of the cholecystokinin receptor EE Cawston, PCH Lam, KG Harikumar, M Dong, AM Ball, ML Augustine, ... Journal of Biological Chemistry 287 (22), 18618-18635, 2012 | 28 | 2012 |
Secretin occupies a single protomer of the homodimeric secretin receptor complex: insights from photoaffinity labeling studies using dual sites of covalent attachment M Dong, PCH Lam, DI Pinon, A Orry, PM Sexton, R Abagyan, LJ Miller Journal of Biological Chemistry 285 (13), 9919-9931, 2010 | 26 | 2010 |
Enzymatic route toward 6‐methylated baeocystin and psilocybin J Fricke, A Sherwood, R Kargbo, A Orry, F Blei, A Naschberger, B Rupp, ... ChemBioChem 20 (22), 2824-2829, 2019 | 25 | 2019 |
Targeting the cyclophilin domain of Ran-binding protein 2 (Ranbp2) with novel small molecules to control the proteostasis of STAT3, hnRNPA2B1 and M-opsin K Cho, A Orry, SE Park, PA Ferreira ACS chemical neuroscience 6 (8), 1476-1485, 2015 | 24 | 2015 |
Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis K Cho, H Patil, E Senda, J Wang, H Yi, S Qiu, D Yoon, M Yu, A Orry, ... Journal of Biological Chemistry 289 (8), 4600-4625, 2014 | 24 | 2014 |